EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease

Ann-Kristin Struckmeier, Ralf Smeets, Cordula Petersen, Christian Betz, Waldemar Wilczak, Martin Gosau

Clinical Oral Investigations · 2026

DOI: 10.1007/s00784-025-06730-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Ann-Kristin Struckmeier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg- Eppendorf, Martinistraße 52, Hamburg, 20246, Germany. a.struckmeier@…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Chemoradiotherapy, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The lymph node management of oral squamous cell carcinoma (OSCC) patients with pN1 neck remains a clinical challenge. This study investigates the impact of different treatment modalities – surgery alone, surgery with postoperative radiotherapy (PORT), and surgery with postoperative chemoradiotherapy (PCRT) – on recurrence and survival outcomes in OSCC patients with pN1 neck.

Methods

A retrospective cohort study was conducted on 98 patients who underwent tumor resection and neck dissection, with a subset receiving adjuvant therapy, between 2011 and 2020. Clinicopathological characteristics were examined for associations with treatment modality using chi-square test. Kaplan-Meier survival curves for overall survival (OS) and recurrence-free survival (RFS), along with the log-rank test, were employed to assess survival over a 10-year period. The prognostic significance of clinicopathological factors and treatment modalities was evaluated using Cox proportional hazards models.

Results

The addition of PORT following surgery significantly reduced the risk of recurrence (HR = 0.280, p = 0.010) and enhanced RFS, particularly at 10 years ( p = 0.010). PORT was also associated with a statistically significant improvement in 5-year-OS ( p = 0.031) compared to surgery alone, with a trend toward improved OS at 10 years ( p = 0.175). In contrast, surgery alone did not yield comparable 10-year survival outcomes. Additionally, the inclusion of PCRT did not show a distinct survival advantage over the combination of surgery and PORT.

Conclusion

Our results indicate that PORT may be considered the standard adjuvant treatment for these patients, as it improves RFS, particularly in the long term, while the addition of chemotherapy does not provide significant additional benefits over PORT alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsChemoradiotherapySquamous Cell Carcinoma of Head and NeckHumansFemaleRetrospective StudiesMaleMiddle AgedNeck DissectionNeoplasm Recurrence, LocalAgedRadiotherapy, AdjuvantNeoplasm StagingSurvival RateAdultPrognosisCarcinoma, Squamous CellLymphatic MetastasisTreatment Outcome

Stichwörter der Autor:innen

ChemoradiotherapyHead and neck squamous cell carcinomaLymph node metastasesNeck dissectionOral squamous cell carcinomaRadiotherapy

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg- Eppendorf, Martinistraße 52, Hamburg, 20246, Germany. a.struckmeier@uke.de.
  • Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg- Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
  • Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Otorhinolaryngology, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.
  • Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Förderung

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Struckmeier, A. K., Smeets, R., Petersen, C., Betz, C., Wilczak, W., & Gosau, M. (2026). Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease. Clinical Oral Investigations. https://doi.org/10.1007/s00784-025-06730-6

Vancouver

Struckmeier AK, Smeets R, Petersen C, Betz C, Wilczak W, Gosau M. Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease. Clinical Oral Investigations. 2026. doi:10.1007/s00784-025-06730-6

BibTeX
@article{Struckmeier2026,
  author = {Struckmeier, Ann-Kristin and Smeets, Ralf and Petersen, Cordula and Betz, Christian and Wilczak, Waldemar and Gosau, Martin},
  title = {Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease},
  journal = {Clinical Oral Investigations},
  year = {2026},
  doi = {10.1007/s00784-025-06730-6}
}
Kostenlos starten →